Communications

Prof. Robin Feldman explains the potential litigation strategy behind Novo Nordisk suing smaller telehealth companies for selling cheaper versions of its weight-loss drug Wegovy.

Analyzing the Trump administration’s efforts to cancel more than $4 billion in foreign aid, Prof. Zachary Price highlights how a litigation strategy focused on technical arguments can yield narrow wins that cumulatively increase executive power.

Prof. Dorit Reiss says the Trump administration’s termination of funding for mRNA vaccines and treatments will “deter innovations.” Reiss was among the experts who say the decision will harm the nation’s ability to stop pandemics.

Prof. David Levine explains why state authority may prevail in high–stakes legal battles over immigration and housing, as a conservative city government and the White House take on the State of California.  

Prof. Kate Weisburd discusses the limitations, both practical and societal, of relying on GPS ankle monitors for youths in a long-form piece on teens in Washington, D.C.

Prof. Joan Williams discusses her new book, “Outclassed,” explaining how a growing “diploma divide” has shifted working-class voting trends and how a focus on shared values could help unify the middle class.

Prof. Robin Feldman examines the legal battlegrounds over generative AI in Hollywood and beyond that are affecting jobs, art, and what it means to create.